Stay updated on Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page.

Latest updates to the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study record's disease terminology in its metadata was updated to reflect Steatotic Liver Disease. This aligns indexing with current clinical nomenclature and can affect searchability and discovery of the study.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page shows a revision label updated from v3.6.0 to v3.6.3, which indicates a software version bump rather than a substantive change to the study details.SummaryDifference0.0%

- Check37 days agoChange DetectedRecruitment status now indicates no longer recruiting ('No longer looking for participants'), and new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, along with a formatting update to the Intervention/Treatment header and an updated revision version (v3.6.0).SummaryDifference0.4%

- Check44 days agoChange DetectedThe page displays revision v3.5.5, replacing the previous v3.5.4 as part of an internal update to the page template. This change does not modify any study data or user-facing content.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a backend or UI update behind the page. No study details or data appear to be affected.SummaryDifference0.0%

- Check87 days agoChange DetectedThe page revision tag was updated from version v3.5.2 to v3.5.3, reflecting a non-content site release/version change.SummaryDifference0.0%

Stay in the know with updates to Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page.